Quest for the right Drug
פורובניר 250 מ"ג/25 מ"ל FUROVENIR 250 MG/25 ML (FUROSEMIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-ורידי : I.V
צורת מינון:
תמיסה לאינפוזיה : SOLUTION FOR INFUSION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Posology : מינונים
4.2 Posology and method of administration Dosage and directions for use Duration of the treatment will depend on usage and is determined by the doctor for each individual. For adults, the maximum recommended dose is 1,500 mg daily, although it may reach 2,000 mg in exceptional cases. For children, the maximum recommended daily dose of FuroVenir for parenteral administration is 1 mg of furosemide per each kilogram of body weight, up to a maximum of 20 mg. Treatment is to be switched to the oral route as soon as possible. FuroVenir 250mg solution for IV infusion should be injected or infused slowly by intravenous route, at a rate not exceeding 4 mg per minute. In patients with severe kidney problems (serum creatinine 5 mg/dl), it is recommended that the rate of infusion does not exceed 2.5 mg per minute. It should not be administered in the form of intravenous bolus. It should be infused using only infusion pumps that control volume or speed in order to avoid a possible risk of accidental overdose. FuroVenir 250 mg solution for IV infusion should not be Mixed in the same syringe or infused together with other medicines. The suitable diluent is isotonic saline solution. No acid solutions should be used. The pH of the solution to be infused should be neutral or lightly alkaline. It is recommended that the ready-to-use solution be administered as soon as possible. FuroVenir should never be infused together with other medication in the same intravenous fluid. Use in children: Parenteral administration is contraindicated for infants and children under the age of 15; this may be carried out only in cases involving a threat to life. Elderly: Elimination of furosemide is generally slower in the elderly. Dosage should be titrated until the required effect is achieved.
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף